Partnership Opportunities

The 3rd Precision Medicine in Inflammatory Bowel Disease Summit provides an unmatched opportunity to connect with senior decision-makers from the immunology, gastrointestinal, and precision medicine sectors, committed to advancing innovation and overcoming challenges in this dynamic field.

Our audience of 80+ senior key opinion leaders are actively pursuing partnerships in data management, AI/ML, technological innovation, multi-omics sequencing and analysis, biomarker development, and other cutting-edge services. They are eager to connect and collaborate with leading solution and service providers driving advancements in these fields.

Our Audience are Looking for:

Who Will You Meet?

Seniority of Attendees - IBD Summit 2025
Companies Attending - 3rd Precision Medicine in Inflammatory Bowel Disease Summit 2025

AI / Bioinformatics / Computation Providers: Tools to analyze complex datasets, enhance patient stratification, and optimize precision medicine approaches

Diagnostics: Advanced technologies to drive biomarker development, improve disease monitoring, and enable targeted therapies

Omics: Multi-omics insights to uncover novel therapeutic targets and refine personalized treatment pathways

CROs: Expertise to streamline clinical trials, ensure regulatory compliance, and accelerate drug development

Why Partner?

Showcase Your Innovative Technologies
Gain Strategic Market Insights
Forge High-Impact Collaborations with Influential Stakeholders

Showcase Your Innovations to IBD Precision Medicine Leaders

Demonstrate your cutting-edge technologies and diagnostics to top decision-makers, gain strategic exposure, and forge key partnerships to drive better IBD outcomes.

Gain Strategic Market Insights to Stay Ahead in the Dynamic IBD Landscape

Steal competitive insights to align your solutions with biopharma priorities in patient stratification, disease monitoring and therapy development to remain a key partner in advancing IBD care.

 

Forge High-Impact Collaborations with Influential Stakeholders from Biopharma, Diagnostics, & Academic Institutions

Connect with biopharma, diagnostics and academia through targeted branding, ensuring you can maximize networking to drive innovation in IBD precision medicine and patient care.

 

Want to get involved?

 

Speak with our partnerships director today to find out what opportunities best suit you.

Eirini headshot